Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Why the cost question matters before you travel
For many international patients, the practical questions about immune cell therapy come right after the medical ones. How is the treatment paid for? What is included? What might be added later? Asking these questions early helps you plan a trip to Japan calmly and avoid surprises once you arrive.
This article explains how to think about cost and payment for NK cell therapy at Grand Green Osaka Umekita Clinic in Osaka. It does not quote prices, because the current fee information belongs on the clinic's official pages and should be confirmed with a doctor or staff member. Instead, it gives you a set of questions to bring to your first conversation.
NK cell therapy is a self-pay treatment in Japan
NK cell therapy is provided as a self-pay (non-insured) medical service in Japan. That means it is not covered by Japan's national health insurance, and it is generally not covered by overseas public insurance either. Whether a private travel or medical insurance plan reimburses any part of it depends entirely on your own policy, so it is worth checking with your insurer before you decide.
The therapy is an immune cell therapy in which your own NK (natural killer) cells are obtained from a standard blood draw, activated and expanded at a specialized facility, and returned by intravenous infusion. In Japan, this kind of treatment is provided under the Act on the Safety of Regenerative Medicine, which requires a treatment plan to be submitted to and accepted by the government. This legal framework is separate from insurance coverage, and it is one of the topics worth discussing with your doctor.
Because the treatment is self-pay, the clinic sets its own fees, and the amount you pay is a matter between you and the clinic. This is why a clear explanation before you commit is so important. A responsible clinic will welcome questions about fees, will explain what is and is not included, and will make clear that the final plan and its cost are confirmed only after a doctor has examined you and reviewed your medical history.
What a clear fee explanation should cover
A useful fee explanation does more than state one number. When you review the Fees section on the clinic's English information page, or ask staff directly, consider whether the following points are explained in plain language.
- The items that are included in the quoted price, such as consultation, blood draw, cell processing, and infusion
- Whether tests, medications, or follow-up visits are charged separately
- How the fee is structured if the plan involves several infusions
- The accepted payment methods and when payment is due
- What happens to the fee if the plan changes or treatment cannot go ahead
If any of these points are unclear, it is reasonable to ask for them in writing. A written explanation is easier to share with family members and with your home doctor, and it gives you time to compare it with your own budget.
Planning the whole journey, not only the treatment
The treatment itself is only one part of the cost of care abroad. NK cell therapy involves a blood draw, a period of cell processing at a facility, and then infusion visits. The clinic can explain how many visits are usually planned and how they are spaced, but your own schedule will depend on the doctor's judgment and your health.
International patients should also think about flights, accommodation in Osaka, local transport, and how long they can realistically stay. Language support matters here as well. Ask whether an interpreter or multilingual staff can join consultations, because understanding the consent and fee documents fully is part of making a sound decision.
If you are currently receiving standard cancer treatment, such as surgery, chemotherapy, or radiation therapy, talk to your oncologist first. NK cell therapy is not a replacement for standard treatment, and your home care team should know about any additional therapy you are considering.
Setting expectations alongside the budget
Cost and expectations are closely linked. Because this is a self-pay therapy, it is natural to want to know what the money is likely to achieve. The honest answer is that outcomes vary from person to person, and no responsible clinic can guarantee a particular result. Research on NK cell approaches is ongoing, and a single study should not be read as proof that the therapy will work for every patient.
A good consultation will discuss the intended purpose of the therapy, its known limits, possible side effects such as temporary fever or fatigue, and the situations in which it may not be suitable. Ask the doctor to explain how your own condition, current treatment, and goals fit into that picture, and how your progress would be reviewed over time.
Questions to bring to your first consultation
Before you book, it can help to write down your questions. The following list is a starting point.
- What is the total estimated cost for the plan you recommend, and what could change it?
- Which items are not included in the estimate?
- How many visits are expected, and over what period?
- What are the known risks, side effects, and limits of this therapy for my situation?
- How can you coordinate with my home doctor and share records?
- Can an interpreter attend my appointments and the consent discussion?
The doctor's examination is what determines whether the therapy is appropriate for you, along with the exact plan, risks, and costs that apply to your situation. Grand Green Osaka Umekita Clinic provides information pages in several languages, including English, so you can review the basics before you contact the clinic and then confirm the details directly with the medical team.
- Self-pay treatmentNot covered by national insurance
- Ask what is includedGet fees explained in writing
- Plan the whole tripVisits, stay and language support
- Doctor confirms the planRisks and costs after examination
This diagram is a conceptual summary of the article content
References
- PubMed: Allogeneic natural killer cell therapy. (2023)
- PubMed: Natural killer cell therapies. (2024)
- PubMed: Natural killer cell-based immunotherapy for cancer. (2025)
- PubMed: Selection and expansion of natural killer cells for NK cell-based immunotherapy. (2016)
- PubMed: Emerging trends in clinical allogeneic CAR cell therapy. (2025)
- PMC: Allogeneic natural killer cell therapy. (2023)
- PMC: Natural Killer Cells in Cancers of Respiratory System and Their Applications in Therapeutic Approaches. (2024)
- PMC: Exploring the NK cell platform for cancer immunotherapy. (2021)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.